Cartesian Therapeutics, Inc.

NASDAQ:RNAC

Biotechnology

Healthcare
$6.12 -4.15%

-$0.41 today

Market cap
$186.68M
Beta
0.78
P/E (TTM)
-1.7
EPS (TTM)
-$5.65
52W Low $5.60High $15.57

Volume 0.23M

Average 0.26M

Private 5-step workspace

Build a RNAC investment thesis

Turn Cartesian Therapeutics, Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.

Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.